Cargando…
Surgeon and medical oncologist peer network effects on the uptake of the 21‐gene breast cancer recurrence score assay
BACKGROUND: Drivers behind the adoption of gene expression profiling in breast cancer oncology have been shown to include exposure to physician colleagues’ use of a given genomic test. We examined adoption of the Oncotype DX 21‐gene breast cancer recurrence score assay (ODX) in the United States aft...
| Autores principales: | , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
John Wiley and Sons Inc.
2021
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7926024/ https://www.ncbi.nlm.nih.gov/pubmed/33455068 http://dx.doi.org/10.1002/cam4.3720 |